Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy.

Atsuhi YanaseToru Sugihara Takahiro AkimotoHirotaka YokoyamaJun KameiAkira FujisakiSatoshi AndoTameto NaoiMitsuya MoritaTetsuya Fujimura

Published in: IJU case reports (2022)

Prostate cancer can occur even when leuprorelin is used for spinal and bulbar muscular atrophy; therefore, checking serum prostate-specific antigen to screen for prostate cancer before leuprorelin administration should be considered.

Keyphrases

prostate cancer
radical prostatectomy
spinal cord
resistance training
high throughput
spinal cord injury
replacement therapy